Breedlove Robert Charles
Officer · PHAT
As of 2026-09-27, Breedlove Robert Charles has 12 Form 4 transactions on record across 1 company — 9 in the trailing 12 months.
Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.
Reconstructed holdings
- Direct $434K
- Indirect $0
| PHAT | direct | 59,465 sh | $434K |
Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.
Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.
Trades by company
Filing ledger
| Date | Company | Action | Shares @ price | Value | Ownership Δ | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| 2025-11-03 | PHAT | Sale | 524 @ $13.51 | $7K | −1.1% of holding | 47,407 | Form 4 |
| 2025-09-05 | PHAT | Sale | 461 @ $12.09 | $6K | −1.0% of holding | 47,931 | Form 4 |
| 2025-07-16 | PHAT | Sale | 1,692 @ $8.36 | $14K | −3.4% of holding | 48,392 | Form 4 |
9 award / exercise / gift records — not counted as purchases
| Date | Company | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|
| 2026-09-03 | PHAT | Withheld for tax | 460 | 59,465 | Form 4 |
| 2026-07-14 | PHAT | Withheld for tax | 1,555 | 59,925 | Form 4 |
| 2026-02-27 | PHAT | Withheld for tax | 964 | 61,894 | Form 4 |
| 2026-02-27 | PHAT | Withheld for tax | 414 | 61,480 | Form 4 |
| 2026-02-27 | PHAT | Award / grant | 13,000 | 60,068 | Form 4 |
| 2026-02-27 | PHAT | Award / grant | 2,790 | 62,858 | Form 4 |
| 2026-01-21 | PHAT | Withheld for tax | 776 | 47,068 | Form 4 |
| 2025-12-18 | PHAT | Withheld for tax | 230 | 47,844 | Form 4 |
| 2025-05-19 | PHAT | Award / grant | 33,000 | 33,000 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.